Hypoxia-inducible factor pathway activation in restless legs syndrome patients.

Patton SM, Ponnuru P, Snyder AM, Podskalny GD, Connor JR.

Eur J Neurol. 2011 Nov;18(11):1329-35. doi: 10.1111/j.1468-1331.2011.03397.x.

The restless legs syndrome: is it more than that?

Shneerson JM.

Br J Hosp Med (Lond). 2011 Apr;72(4):219-23. Review. No abstract available.

Efficacy and augmentation during 6 months of double-blind pramipexole for restless legs syndrome.

Högl B, Garcia-Borreguero D, Trenkwalder C, Ferini-Strambi L, Hening W, Poewe W, Brenner SS, Fraessdorf M, Busse M, Albrecht S, Allen RP.

Sleep Med. 2011 Apr;12(4):351-60. doi: 10.1016/j.sleep.2010.12.007.

A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome.

Silver N, Allen RP, Senerth J, Earley CJ.

Sleep Med. 2011 May;12(5):440-4. doi: 10.1016/j.sleep.2010.11.002.

Restless abdomen: a phenotypic variant of restless legs syndrome.

Pérez-Díaz H, Iranzo A, Rye DB, Santamaría J.

Neurology. 2011 Sep 27;77(13):1283-6. doi: 10.1212/WNL.0b013e318230207a.

Development and validation of a subjective post sleep diary (SPSD) to assess sleep status in subjects with restless legs syndrome.

Calloway M, Bharmal M, Hill-Zabala C, Allen R.

Sleep Med. 2011 Aug;12(7):704-10. doi: 10.1016/j.sleep.2010.09.020.

Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1.

Winkelmann J, Czamara D, Schormair B, Knauf F, Schulte EC, Trenkwalder C, Dauvilliers Y, Polo O, Högl B, Berger K, Fuhs A, Gross N, Stiasny-Kolster K, Oertel W, Bachmann CG, Paulus W, Xiong L, Montpla

PLoS Genet. 2011 Jul;7(7):e1002171. doi: 10.1371/journal.pgen.1002171. Erratum in: PLoS Genet. 2011 Aug;7(8). doi: 10.1371/annotation/393ad2d3-df4f-4770-87bc-00bfabf79362.

Effects of acute dopamine-agonist treatment in restless legs syndrome on heart rate variability during sleep.

Manconi M, Ferri R, Zucconi M, Clemens S, Rundo F, Oldani A, Ferini-Strambi L.

Sleep Med. 2011 Jan;12(1):47-55. doi: 10.1016/j.sleep.2010.03.019.

[Restless legs syndrome: the most prevalent unknown" disorder]."

Lindner A, Novák M, Molnár MZ.

Orv Hetil. 2011 Feb 13;152(7):259-66. doi: 10.1556/OH.2011.29035. Hungarian.

Restless legs syndrome in multiple sclerosis.

Aydar G, Kurt S, Karaer Unaldi H, Erkorkmaz U.

Eur Neurol. 2011;65(5):302-6. doi: 10.1159/000327315.

Prevalence of restless legs syndrome in patients with irritable bowel syndrome.

Basu PP, Shah NJ, Krishnaswamy N, Pacana T.

World J Gastroenterol. 2011 Oct 21;17(39):4404-7. doi: 10.3748/wjg.v17.i39.4404.

Restless legs syndrome in patients on hemodialysis.

Salman SM.

Saudi J Kidney Dis Transpl. 2011 Mar;22(2):368-72.

Migraine and restless legs syndrome: is there an association?

Cannon PR, Larner AJ.

J Headache Pain. 2011 Aug;12(4):405-9. doi: 10.1007/s10194-011-0357-x. Review.

Prevalence and disease burden of primary restless legs syndrome: results of a general population survey in the United States.

Allen RP, Bharmal M, Calloway M.

Mov Disord. 2011 Jan;26(1):114-20. doi: 10.1002/mds.23430.

Efficacy, safety and dose-response of pramipexole in Japanese patients with primary restless legs syndrome: randomized trial.

Inoue Y, Kuroda K, Hirata K, Uchimura N, Kagimura T, Shimizu T.

Neuropsychobiology. 2011;63(1):35-42. doi: 10.1159/000322289.